Is VictoryShares US Discovery Enhanced Volatility Wtd ETF (CSF) a good stock to buy?

Olyth's institutional analysis of CSF reveals an Altman Z-Score of undefined and a Piotroski F-Score of undefined/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if CSF fits their risk profile.

Does CSF pay a dividend?

VictoryShares US Discovery Enhanced Volatility Wtd ETF does not currently pay a dividend to its shareholders.

How much debt and cash flow does CSF have?

In its latest reporting period, VictoryShares US Discovery Enhanced Volatility Wtd ETF generated $N/A in Free Cash Flow against a total debt load of $N/A.

What is VictoryShares US Discovery Enhanced Volatility Wtd ETF's Return on Equity (ROE)?

VictoryShares US Discovery Enhanced Volatility Wtd ETF (CSF) has a Return on Equity (ROE) of N/A, representing its profitability relative to shareholder equity.

CSF

VictoryShares US Discovery Enhanced Volatility Wtd ETF · Financial Services

51.03

0.28%(+0.14)

51.31

0.56%(+0.28)

After Hours

Last Updated: — ET

52W L: $47.7252W H: $60.63

$0.00

CHG+0.00 (+0.00%)

H$0.00

L$0.00

CSF (1h)

Company Profile

The VictoryShares US Discovery Enhanced Volatility Wtd ETF seeks to provide investment results that track the performance of the Nasdaq VictoryUS Small Cap 500 Long/Cash Volatility Weighted Index (the “Long/Cash Index”) before fees and expenses. Volatility Weighting Methodology Combines fundamental criteria and volatility weighting in an effort to outperform traditional cap-weighted indexing strategies. About the Long/Cash Index The Long/Cash Index tactically reduces its exposure to the equity markets during periods of significant market declines and reinvests when market prices have further declined or rebounded. The Nasdaq Victory US Small Cap 500 Long/Cash Volatility Weighted Index is based on the month-end price of the Nasdaq Victory US Small Cap 500 Volatility Weighted Index (the “Reference Index”). The exit and reinvestment methodology of the Long/Cash Index is based on the month-end value of the Reference Index relative to its All-Time Highest Daily Closing Value (“AHDCV”). AHDCV is the highest daily closing price the Reference Index has achieved since its inception date.

Sector

Financial Services

Industry

Asset Management

IPO Date

2014-08-01

Beta

0.59

CSF

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA

Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy Results in Sustained, Significant Reductions in CSF-HS and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome (MPS IIIA)

Digital Realty Taps Malaysia for Expansion Through CSF Advisers Buyout